6 December 2023
29th SCI Annual Review Meeting – Organic Synthesis: New Technologies and Applications
Organised by:
SCI’s Young Chemists’ Panel
SCI, London, UK
Registration Closed
This event is no longer available for registration.
Share this event
Synopsis
The 29th Annual Review Meeting – Organic Synthesis: New Technologies and Applications, organised by SCI's Young Chemists’ Panel, will address key areas of contemporary synthetic organic chemistry. An exciting line-up of leading early career academics will deliver a series of review lectures covering a range of topics, including molecular motors, organofluorine chemistry, protein interactions in medicinal chemistry, and synthetic electrochemistry. The meeting will deliver a comprehensive overview of the material, highlight new methods, and introduce (potential) industrial applications. The review lectures will be supported by two plenary speakers: Dr James Bull from Imperial College London and Prof Charlotte Williams from the University of Oxford.
Attendees
The meeting is ideally suited to those working in the pharmaceutical, biotechnology or agrochemical industries who want to develop their knowledge in key areas. It is also aimed at those in academia, particularly graduates and post-graduates with a background in synthesis and catalysis. An electronic delegate pack will be provided to all participants containing the lecture materials as well as extensive literature references that will be an excellent resource for years to come.
Posters
If you would like to present a poster, please send an abstract of maximum one A4 page or 300 words including schemes and references and indicating title and authors to conferences@soci.org by Friday 3 November 2023 with the subject line “29th Annual review meeting – poster submission” You can download an abstract template here.
Exhibition and sponsorship
An exhibition will take place alongside the conference during refreshment breaks for companies and related organisations who may wish to exhibit. For further information and prices, please email conferences@soci.org. Spaces are limited and will be allocated on a first come, first served basis.
Wednesday 6 December 2023
- 10:00
- Registration and refreshments
- 10:30
- Welcome and introduction
- 10:35
- Advances in Single Bond Rotary Molecular Motors
Dr Beatrice Collins, University of Bristol - 11:20
- Refreshment break, posters and exhibition
- 11:40
- An Introduction to Organofluorine Chemistry
Dr William Brittain, Durham University - 12:25
- Keynote lecture: Synthesis of Small Rings and Heterocycles
Dr James Bull, Imperial College London - 13:25
- Lunch, posters and exhibition
- 14:15
- We're getting better all the time, so why is drug discovery getting harder?
Dr Kate Harris, Newcastle University - 15:00
- Organic Electrochemistry
Dr Louis Morrill, University of Cardiff - 15:45
- Refreshment break, posters and exhibition
- 16:15
- Keynote lecture: Switchable Polymerization Catalyses – Order From Mixtures
Prof Charlotte Williams, University of Oxford - 17:15
- Networking reception
SCI’s Young Chemists’ Panel are committed to promoting diversity and equality in the chemical sciences. We aim to identify high quality speakers for all our conferences with inclusivity of gender and ethnicity. Attendees from all backgrounds and ages are welcome.
Venue and Contact
SCI
14/15 Belgrave Square
London
SW1X 8PS
Conference Team
Tel: +44 (0)20 7598 1561
Email: conferences@soci.org
Fees
Before early bird - ends 25 October 2023
SCI Member - £125
Non-member - £175
SCI Student member - £50
After early bird
SCI Member - £175
Non-member - £225
SCI Student member - £65
Become an SCI Member and save on this and future events
See Membership OptionsSign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking Process/Deadlines
CPD Info
SCI Members attending this meeting are able to claim CPD points.
Exhibitors
Sponsors
Organising Committee
Roly Armstrong, Newcastle University
Ben Partridge, University of Sheffield
James Taylor, University of Bath
Will Waddington, Pfizer
Rob Griffiths, Celeris Therapeutics